Company Filing History:
Years Active: 1997
Title: Innovations of Sunan Fang in Cholecystokinin Research
Introduction
Sunan Fang is a notable inventor based in Tucson, AZ (US). He has made significant contributions to the field of biochemistry, particularly in the development of receptor selective analogues of cholecystokinin-8. His work has implications for understanding hormone interactions and potential therapeutic applications.
Latest Patents
Sunan Fang holds a patent for "Receptor selective analogues of cholecystokinin-8." This patent describes analogues of cholecystokinin-8 that are receptor selective, differing from the natural hormone by alterations in at least one of the two, three, or six position amino acids of the natural sequence. This innovation represents a step forward in the design of targeted hormone therapies.
Career Highlights
Sunan Fang is associated with the Arizona Technology Development Corporation, where he applies his expertise in biochemistry to advance research and development. His work has garnered attention for its potential to influence medical treatments and improve patient outcomes.
Collaborations
Sunan Fang collaborates with Victor J Hruby, a fellow researcher in the field. Their partnership enhances the research efforts and contributes to the advancement of knowledge in hormone analogues.
Conclusion
Sunan Fang's innovative work in receptor selective analogues of cholecystokinin-8 showcases his commitment to advancing biochemistry and its applications in medicine. His contributions are valuable to the scientific community and hold promise for future developments in therapeutic strategies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.